Kenvue Inc. (KVUE)
The price, the headline numbers and the latest news, in one place.
Kenvue Inc. (KVUE) Stock Price, Analysis & Data
| Bid | 17.78 |
| Market Cap | 34.2B |
| Revenue (ttm) | 15.4B |
| Net Income (ttm) | 1.66B |
| 0.43 | |
| 0.85 | |
| 20.93 | |
| 14.33 | |
| P/B (ttm) | 3.24 |
| P/S (ttm) | 2.22 |
| Earnings Date | Nov 5, 2026 |
| Ask | 17.79 |
| Volume | 64,356,966 |
| Avg. Volume (20D) | 20,605,652 |
| Open | 17.75 |
| Previous Close | 17.75 |
| Day's Range | 17.72 - 17.92 |
| 52-Week Range | 14.02 - 20.13 |
| Analyst | Hold |
| Price Target | 19 (6.8%) |
| Dividends | $0.84 (4.73%) |
| Ex-Dividend Date | Sep 21, 2026 |
About KVUE
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, d...
Financial Performance
In 2025, Kenvue's revenue was 15.12B, a decrease of -2.14% compared to the previous year's 15.46B. Earnings were 1.47B, an increase of 42.72%.
Financial StatementsAnalyst Forecast
According to 12 analyst ratings, the average rating for KVUE stock is "Hold". The 12-month stock price forecast is 19, which is upside of 6.8% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $3.96B misses estimates by $0, with 3.02% YoY growth.
- EPS of 0.31 misses estimates by -0.01, with 6.90% YoY growth.
Analysts project revenue of ... Upgrade
